These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 21236467)
1. Expression of Pirh2, a p27(Kip1) ubiquitin ligase, in hepatocellular carcinoma: correlation with p27(Kip1) and cell proliferation. Huang X; Qian X; Cheng C; He S; Sun L; Ke Q; Zhang L; Pan X; He F; Wang Q; Meng J; Ni R; Shen A Hum Pathol; 2011 Apr; 42(4):507-15. PubMed ID: 21236467 [TBL] [Abstract][Full Text] [Related]
2. Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. Hattori T; Isobe T; Abe K; Kikuchi H; Kitagawa K; Oda T; Uchida C; Kitagawa M Cancer Res; 2007 Nov; 67(22):10789-95. PubMed ID: 18006823 [TBL] [Abstract][Full Text] [Related]
3. Regulation of p27 by ubiquitin ligases and its pathological significance in human lung carcinomas. Dobashi Y; Tsubochi H; Minegishi K; Kitagawa M; Otani S; Ooi A Hum Pathol; 2017 Aug; 66():67-78. PubMed ID: 28601655 [TBL] [Abstract][Full Text] [Related]
4. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1). Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332 [TBL] [Abstract][Full Text] [Related]
5. p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection. Wang XM; Yang LY; Guo L; Fan C; Wu F Cancer; 2009 Oct; 115(19):4554-63. PubMed ID: 19551892 [TBL] [Abstract][Full Text] [Related]
6. CACYBP Enhances Cytoplasmic Retention of P27 Lian YF; Huang YL; Zhang YJ; Chen DM; Wang JL; Wei H; Bi YH; Jiang ZW; Li P; Chen MS; Huang YH Theranostics; 2019; 9(26):8392-8408. PubMed ID: 31754404 [TBL] [Abstract][Full Text] [Related]
7. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma. Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595 [TBL] [Abstract][Full Text] [Related]
8. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis. Qin LF; Ng IO Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219 [TBL] [Abstract][Full Text] [Related]
9. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
10. Changes in Pirh2 and p27kip1 expression following traumatic brain injury in adult rats. Wu X; Shi W; Zhao W; Shao B; Yuan Q; Li C; Zhang S; Sun B; Wu Q; Chen J J Mol Neurosci; 2012 Jan; 46(1):184-91. PubMed ID: 21728064 [TBL] [Abstract][Full Text] [Related]
11. High expression of Pirh2, an E3 ligase for p27, is associated with low expression of p27 and poor prognosis in head and neck cancers. Shimada M; Kitagawa K; Dobashi Y; Isobe T; Hattori T; Uchida C; Abe K; Kotake Y; Oda T; Suzuki H; Hashimoto K; Kitagawa M Cancer Sci; 2009 May; 100(5):866-72. PubMed ID: 19445020 [TBL] [Abstract][Full Text] [Related]
12. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743 [TBL] [Abstract][Full Text] [Related]
13. SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma. Hu L; Liu M; Chen L; Chan TH; Wang J; Huo KK; Zheng BJ; Xie D; Guan XY Carcinogenesis; 2012 Aug; 33(8):1581-8. PubMed ID: 22570270 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway. Wang H; Liu XB; Chen JH; Wang QQ; Chen JP; Xu JF; Sheng CY; Ni QC Exp Mol Pathol; 2014 Oct; 97(2):191-201. PubMed ID: 25036402 [TBL] [Abstract][Full Text] [Related]
15. The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity. Ranchal I; González R; Bello RI; Ferrín G; Hidalgo AB; Linares CI; Aguilar-Melero P; González-Rubio S; Barrera P; Marchal T; Nakayama KI; de la Mata M; Muntané J Int J Cancer; 2009 Nov; 125(10):2270-80. PubMed ID: 19672859 [TBL] [Abstract][Full Text] [Related]
16. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396 [TBL] [Abstract][Full Text] [Related]
17. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma. Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785 [TBL] [Abstract][Full Text] [Related]
18. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239 [TBL] [Abstract][Full Text] [Related]
19. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma. Shehata MA; Nosseir HR; Nagy HM; Farouk G Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156 [TBL] [Abstract][Full Text] [Related]
20. The DNA damage repair protein Ku70 regulates tumor cell and hepatic carcinogenesis by interacting with FOXO4. Zhang T; Zhang X; Shi W; Xu J; Fan H; Zhang S; Ni R Pathol Res Pract; 2016 Mar; 212(3):153-61. PubMed ID: 26797321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]